By not developing TAF right away, GILD delayed the issuance of TAF patents, thereby extending patent protection for the company's overall HIV franchise.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.